← Compare landing
Merck KGaA vs Roquette Pharma Solutions
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Merck KGaA | Roquette Pharma Solutions |
|---|---|---|
| Summary | Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea. | Roquette is a leading global provider of plant-based ingredients, excipients, and solutions for the pharmaceutical and healthcare industries. |
| Services | Data not yet provided. |
|
| Modalities | Data not yet provided. |
|
| Development capabilities | Data not yet provided. | Data not yet provided. |
| Manufacturing capabilities | Data not yet provided. |
|
| Locations |
|
|
| Certifications | Data not yet provided. |
|
Find similar companies
Merck KGaA alternatives · Roquette Pharma Solutions alternatives
Markdown mirror: /compare/merck-kgaa/roquette.md